Detalhe da pesquisa
1.
Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNß-Driven Antitumor Immunity.
Cancer Res
; 79(20): 5394-5406, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431457